167 related articles for article (PubMed ID: 30873742)
1. Glutathione S-transferase omega 1 inhibition activates JNK-mediated apoptotic response in breast cancer stem cells.
Manupati K; Debnath S; Goswami K; Bhoj PS; Chandak HS; Bahekar SP; Das A
FEBS J; 2019 Jun; 286(11):2167-2192. PubMed ID: 30873742
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs.
Manupati K; Dhoke NR; Debnath T; Yeeravalli R; Guguloth K; Saeidpour S; De UC; Debnath S; Das A
FEBS J; 2017 Jun; 284(12):1830-1854. PubMed ID: 28398698
[TBL] [Abstract][Full Text] [Related]
3. Glutathione transferase omega 1-1 (GSTO1-1) plays an anti-apoptotic role in cell resistance to cisplatin toxicity.
Piaggi S; Raggi C; Corti A; Pitzalis E; Mascherpa MC; Saviozzi M; Pompella A; Casini AF
Carcinogenesis; 2010 May; 31(5):804-11. PubMed ID: 20106899
[TBL] [Abstract][Full Text] [Related]
4. Glutathione-S-transferase omega 1 (GSTO1-1) acts as mediator of signaling pathways involved in aflatoxin B1-induced apoptosis-autophagy crosstalk in macrophages.
Paul S; Jakhar R; Bhardwaj M; Kang SC
Free Radic Biol Med; 2015 Dec; 89():1218-30. PubMed ID: 26561775
[TBL] [Abstract][Full Text] [Related]
5. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
Ahmadipour F; Noordin MI; Mohan S; Arya A; Paydar M; Looi CY; Keong YS; Siyamak EN; Fani S; Firoozi M; Yong CL; Sukari MA; Kamalidehghan B
Drug Des Devel Ther; 2015; 9():1193-208. PubMed ID: 25759564
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S‑transferase ω 1 promotes the proliferation, migration and invasion, and inhibits the apoptosis of non‑small cell lung cancer cells, via the JAK/STAT3 signaling pathway.
Wang K; Zhang FL; Jia W
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236161
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor.
Ramkumar K; Samanta S; Kyani A; Yang S; Tamura S; Ziemke E; Stuckey JA; Li S; Chinnaswamy K; Otake H; Debnath B; Yarovenko V; Sebolt-Leopold JS; Ljungman M; Neamati N
Nat Commun; 2016 Oct; 7():13084. PubMed ID: 27703239
[TBL] [Abstract][Full Text] [Related]
8. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
Giri U; Terry NH; Kala SV; Lieberman MW; Story MD
Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
[TBL] [Abstract][Full Text] [Related]
9. Potent and selective inhibitors of glutathione S-transferase omega 1 that impair cancer drug resistance.
Tsuboi K; Bachovchin DA; Speers AE; Spicer TP; Fernandez-Vega V; Hodder P; Rosen H; Cravatt BF
J Am Chem Soc; 2011 Oct; 133(41):16605-16. PubMed ID: 21899313
[TBL] [Abstract][Full Text] [Related]
10. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
Sambi M; Samuel V; Qorri B; Haq S; Burov SV; Markvicheva E; Harless W; Szewczuk MR
Drug Des Devel Ther; 2020; 14():1995-2019. PubMed ID: 32546966
[TBL] [Abstract][Full Text] [Related]
11. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
Ózsvári B; Sotgia F; Lisanti MP
Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
[TBL] [Abstract][Full Text] [Related]
12. c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.
Xie X; Kaoud TS; Edupuganti R; Zhang T; Kogawa T; Zhao Y; Chauhan GB; Giannoukos DN; Qi Y; Tripathy D; Wang J; Gray NS; Dalby KN; Bartholomeusz C; Ueno NT
Oncogene; 2017 May; 36(18):2599-2608. PubMed ID: 27941886
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen receptor-regulated glutathione S-transferase mu 3 expression attenuates hydrogen peroxide-induced cytotoxicity, which confers tamoxifen resistance on breast cancer cells.
Lin JH; Tu SH; Chen LC; Huang CC; Chang HL; Cheng TC; Chang HW; Wu CH; Wu HC; Ho YS
Breast Cancer Res Treat; 2018 Nov; 172(1):45-59. PubMed ID: 30054830
[TBL] [Abstract][Full Text] [Related]
14. Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-
Mastelić A; Čikeš Čulić V; Režić Mužinić N; Vuica-Ross M; Barker D; Leung EY; Reynisson J; Markotić A
Drug Des Devel Ther; 2017; 11():759-769. PubMed ID: 28352152
[TBL] [Abstract][Full Text] [Related]
15. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
16. Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells.
Velázquez-Quesada I; Ruiz-Moreno AJ; Casique-Aguirre D; Aguirre-Alvarado C; Cortés-Mendoza F; de la Fuente-Granada M; García-Pérez C; Pérez-Tapia SM; González-Arenas A; Segura-Cabrera A; Velasco-Velázquez MA
Drug Des Devel Ther; 2020; 14():1799-1811. PubMed ID: 32494122
[TBL] [Abstract][Full Text] [Related]
17. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.
Mandlekar S; Yu R; Tan TH; Kong AN
Cancer Res; 2000 Nov; 60(21):5995-6000. PubMed ID: 11085519
[TBL] [Abstract][Full Text] [Related]
18. Activation of CD44-Lipoprotein lipase axis in breast cancer stem cells promotes tumorigenesis.
Manupati K; Yeeravalli R; Kaushik K; Singh D; Mehra B; Gangane N; Gupta A; Goswami K; Das A
Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166228. PubMed ID: 34311079
[TBL] [Abstract][Full Text] [Related]
19. A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation.
Jafari SM; Joshaghani HR; Panjehpour M; Aghaei M
Cell Oncol (Dordr); 2018 Feb; 41(1):61-72. PubMed ID: 29218545
[TBL] [Abstract][Full Text] [Related]
20. ZEB1 potentiates chemoresistance in breast cancer stem cells by evading apoptosis.
Shivhare S; Choudhury S; Singh D; Das A
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119528. PubMed ID: 37356459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]